Ann Lee-Karlon

Dr. Ann Lee-Karlon is Chief Operating Officer of Altos Labs and leads scientific and business operations for the company. She was previously Senior Vice President at Genentech, leading portfolio strategy and operations with oversight for over 35 drug development teams in the pipeline. She also led the anti- CD20 immunology team, including the development of Ocrevus® for multiple sclerosis. Dr. Lee-Karlon holds a BS in bioengineering from UC Berkeley, MBA from Stanford, and Ph.D. in bioengineering from UCSD, and completed her postdoc at University College London as a National Science Foundation Fellow. She serves on the Dean's boards for UC Berkeley and UCSD schools of engineering. Dr. Lee-Karlon was elected a Fellow of the American Institute of Medical and Biological Engineering and is a Fellow of the Aspen Institute.